Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W G Peters

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
The Netherlands Journal of Medicine|October 22, 2003
Compassionate use programme of irinotecan in colorectal cancer patients in The NetherlandsW W ten Bokkel Huinink, C J van Groeningen, E E Voest, et al.
The Netherlands Journal of Medicine|April 9, 2015
The standardised mortality ratio: the proper quality indicator in acute leukaemia?L Saes, W G Peters, R Schaafsma, et al.
Infection|May 1, 1990
Respiratory failure elicited by streptococcal septicaemia in patients treated with cytosine arabinoside, and its prevention by penicillinH F Guiot, W G Peters, P J van den Broek, et al.
Scandinavian Journal of Haematology|January 1, 1985
Intermediate and high-dose ARA-C and m-AMSA (or daunorubicin) as remission and consolidation treatment for patients with relapsed acute leukaemia and lymphoblastic non-Hodgkin lymphomaR Willemze, W G Peters, M B van Hennik, et al.
Annals of Hematology|February 1, 1991
Bone marrow transplantation or chemotherapy as post-remission treatment of adult acute myelogenous leukemiaR Willemze, W E Fibbe, J C Kluin-Nelemans, et al.
International Journal of Integrated Care|August 10, 2006
Organisational design for an integrated oncological departmentC L Meiss-de Haas, H Falkmann, J Douma, et al.
European Journal of Cancer (Oxford, England : 1990)|July 29, 2011
Chronic lymphocytic leukaemia in the Netherlands: trends in incidence, treatment and survival, 1989-2008E C van den Broek, A P Kater, S A M van de Schans, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 25, 2015
Quality of life of patients with chronic lymphocytic leukaemia in the Netherlands: results of a longitudinal multicentre studyK M Holtzer-Goor, M R Schaafsma, P Joosten, et al.
Leukemia Research|November 26, 2013
Real-world costs of chronic lymphocytic leukaemia in the NetherlandsK M Holtzer-Goor, C A M Bouwmans-Frijters, M R Schaafsma, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
The Netherlands Journal of Medicine|October 22, 2003
Compassionate use programme of irinotecan in colorectal cancer patients in The NetherlandsW W ten Bokkel Huinink, C J van Groeningen, E E Voest, et al.
The Netherlands Journal of Medicine|April 9, 2015
The standardised mortality ratio: the proper quality indicator in acute leukaemia?L Saes, W G Peters, R Schaafsma, et al.
Infection|May 1, 1990
Respiratory failure elicited by streptococcal septicaemia in patients treated with cytosine arabinoside, and its prevention by penicillinH F Guiot, W G Peters, P J van den Broek, et al.
Scandinavian Journal of Haematology|January 1, 1985
Intermediate and high-dose ARA-C and m-AMSA (or daunorubicin) as remission and consolidation treatment for patients with relapsed acute leukaemia and lymphoblastic non-Hodgkin lymphomaR Willemze, W G Peters, M B van Hennik, et al.
Annals of Hematology|February 1, 1991
Bone marrow transplantation or chemotherapy as post-remission treatment of adult acute myelogenous leukemiaR Willemze, W E Fibbe, J C Kluin-Nelemans, et al.
International Journal of Integrated Care|August 10, 2006
Organisational design for an integrated oncological departmentC L Meiss-de Haas, H Falkmann, J Douma, et al.
European Journal of Cancer (Oxford, England : 1990)|July 29, 2011
Chronic lymphocytic leukaemia in the Netherlands: trends in incidence, treatment and survival, 1989-2008E C van den Broek, A P Kater, S A M van de Schans, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 25, 2015
Quality of life of patients with chronic lymphocytic leukaemia in the Netherlands: results of a longitudinal multicentre studyK M Holtzer-Goor, M R Schaafsma, P Joosten, et al.
Leukemia Research|November 26, 2013
Real-world costs of chronic lymphocytic leukaemia in the NetherlandsK M Holtzer-Goor, C A M Bouwmans-Frijters, M R Schaafsma, et al.
Pageof 4